Canada Bans Pfizer Inc. Arthritis Drug Bextra; Will Not Return To Market
Published: Dec 16, 2005
OTTAWA, Dec 16 (Reuters) - Canada banned Pfizer Inc.'s (PFE.N: Quote, Profile, Research) arthritis drug Bextra on Friday because of risks of heart attacks and strokes.